Tag - ZetrOZ Systems

14 Jan

ZetrOZ Systems Announces Expansion of Sustained Acoustic Medicine (SAM) Continuing Medical Education Courses

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device and global leader in the development of SAM technology, announces the expansion of the nationally recognized continuing medical education program, designed to train, and certify professionals including nurses, athletic trainers, physicians and physical therapists on the use and application of SAM technology. Courses will be led through a SAM Learning Management System virtually by Dr. Rod Walters and Dr. Rajiv Mallipudi, who […]

Portfolio News Read more...
30 Dec

ZetrOZ Systems’ Wearable Ultrasound Device, SAM, Receives Expanded FDA Re-Approval, Positioning the Company for Market Growth in 2021

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, is the global leader in development of SAM technologies. With its reapproval for expanded use in 2020, the use of SAM ultrasound technology in both professional and at-home applications is expected to increase market growth significantly over the next several years. Read more >>

Portfolio News Read more...
16 Dec

New Research Study Shows Efficacy of Sustained Acoustic Medicine as Add-on Therapy in Treating Sport-Related Injuries and Returning Athletes to Play

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device, was recently evaluated in a research study published in the Global Journal of Orthopedics Research, which measured the effectiveness of SAM treatment to reduce pain and improve function in athletes in conjunction with traditional therapies following sports-related musculoskeletal injuries. Read more >>

Portfolio News Read more...
10 Dec

All-Star Athletes Across Sports Are Seeing Injury Recovery Without Surgery or Medication Using SAM 2.0 Wearable Ultrasound

ZetrOZ Systems, developers of the Sustained Acoustic Medicine (SAM) wearable ultrasound, an FDA-cleared bio regenerative medical device supported by the National Institutes of Health, announces that the SAM family of medical ultrasound device has received positive reviews and feedback from professional athletes across a number of different sports and disciplines. The medical device’s ability to provide relief from muscle injury and pain showcases SAM’s ability to deal with the physical rigors of professional sports and is perfect for home […]

Portfolio News Read more...
25 Nov

ZetrOZ Systems is Selected Among the Most Innovative Healthcare Companies in 2020

ZetrOZ Systems, developers of the SAM family of ultrasound products, FDA-cleared bio regenerative medical devices supported with over 30 clinical efficacy studies, is proud to be recognized as one of the most innovative companies in healthcare, announcing its inclusion into the 2020 Inaugural List of Most Innovative Companies in Healthcare. The 2020 listing of Most Innovative companies in healthcare includes 60 companies from 30 different categories of innovation within the medical industry. Read more >>

Portfolio News Read more...
18 Nov

SAM by ZetrOZ is the New, Go-To, Cost-Effective Treatment for Knee Arthritis Pain

ZetrOZ Systems, developers of Sustained Acoustic Medicine (SAM), a wearable, home-use, FDA-cleared bio regenerative medical device, announces that its product has been recognized as a cost-effective treatment for patients suffering from knee pain relating to arthritis in a recent research study published in the Journal of Orthopaedic Surgery and Research. Read more >>

Portfolio News Read more...
29 Oct

SAM Sport’s Ability to Help Athletes Recover from Injury Without Surgery is Gaining Recognition from Enthusiasts Within the Tennis Community

SAM Sport, an FDA-cleared bio regenerative medical device that helps reduce pain associated with tendon, ligament, and muscle injuries is receiving an increased amount of attention for its ability to help tennis players recover without surgery. SAM by ZetrOZ Systems provides proven soft tissue and chronic pain relief through continuous ultrasound treatment. Read more >>

Portfolio News Read more...
23 Oct

ZetrOZ Receives Funding from the National Institute of Health to Find New Ways to Reduce Arthritic Pain for Over 60 Million Americans Using Non-Narcotic, Non-Surgical Technology

ZetrOZ Systems, developers of sustained acoustic medicine (SAM), an FDA-cleared home-use ultrasound device that helps reduce pain associated with tendon, ligament, and muscle injuries, has received funding from the National Institute of Health (NIH) to find a way to reduce arthritic pain utilizing non-surgical, non-narcotic technology. Read more >>

Portfolio News Read more...
13 Oct

Major League Baseball Teams Stand by ZetrOZ’s SAM 2.0 Ability to Help Athletes Recover From Muscle Injury Without Surgery

SAM 2.0, an FDA-cleared 2020 bio regenerative medical device that helps reduce pain associated with tendon, ligament, and muscle injuries has received positive feedback from athletes at nearly every skill level for its ability to penetrate deep into the tissue. Most notably, athletic staff from a number of professional major league baseball teams have shared their positive experiences with Sustained Acoustic Medicine-SAM, and its ability to accelerate the natural healing process without the need for surgery. Read more >>

Portfolio News Read more...